2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Cardiac Rupture, Traumatic in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tahara, N | 1 |
| Akiyama, R | 1 |
| Wang, J | 1 |
| Kawakami, H | 1 |
| Bessho, Y | 1 |
| Kawakami, Y | 1 |
| Zheng, WF | 1 |
| Zhang, SY | 1 |
| Ma, HF | 1 |
| Chang, XW | 1 |
| Wang, H | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Cardiac Rupture, Traumatic
| Article | Year |
|---|---|
The FGF-AKT pathway is necessary for cardiomyocyte survival for heart regeneration in zebrafish.
Topics: Animals; Animals, Genetically Modified; Cell Proliferation; Cell Survival; Chromones; Fibroblast Gro | 2021 |
C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
Topics: Adipokines; Animals; Cardiotoxicity; Cell Line; Chromones; Dependovirus; Doxorubicin; Gene Expressio | 2019 |